Leap Therapeutics
Stock Forecast, Prediction & Price Target
Leap Therapeutics Financial Estimates
Leap Therapeutics Revenue Estimates
Leap Therapeutics EBITDA Estimates
Leap Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.5M N/A | $0 -100% | $0 0% | Avg: $34.48M Low: $34.48M High: $34.48M avg. 0% | Avg: $1.5M Low: $1.5M High: $1.5M avg. -95.65% | Avg: $47.32M Low: $47.32M High: $47.32M avg. 3055.08% | Avg: $67.38M Low: $67.38M High: $67.38M avg. 42.39% |
Net Income
% change YoY
| $-40.58M N/A | $-54.59M -34.51% | $-81.41M -49.12% | Avg: $-62.13M Low: $-39.45M High: $-21.67M avg. 23.67% | Avg: $-67.90M Low: $-44.77M High: $-17.99M avg. -9.28% | Avg: $-26.53M Low: $-26.53M High: $-26.53M avg. 60.91% | Avg: $-20.52M Low: $-20.52M High: $-20.52M avg. 22.65% |
EBITDA
% change YoY
| $-40.19M N/A | $-53.78M -33.82% | $-80.98M -50.56% | Avg: $6.89M Low: $6.89M High: $6.89M avg. 108.51% | Avg: $299.99K Low: $299.99K High: $299.99K avg. -95.65% | Avg: $9.46M Low: $9.46M High: $9.46M avg. 3055.09% | Avg: $13.47M Low: $13.47M High: $13.47M avg. 42.39% |
EPS
% change YoY
| -$4.73 N/A | -$4.82 -1.90% | -$3.98 17.42% | Avg: -$1.55 Low: -$1.93 High: -$1.06 avg. 61.18% | Avg: -$1.53 Low: -$2.19 High: -$0.88 avg. 1.29% | Avg: -$1.3 Low: -$1.3 High: -$1.3 avg. 14.88% | Avg: -$1 Low: -$1 High: -$1 avg. 22.65% |
Operating Expenses
% change YoY
| $41.7M N/A | $54.71M 31.20% | $87.04M 59.08% | Avg: $114.40M Low: $114.40M High: $114.40M avg. 31.44% | Avg: $4.97M Low: $4.97M High: $4.97M avg. -95.65% | Avg: $157.00M Low: $157.00M High: $157.00M avg. 3055.08% | Avg: $223.56M Low: $223.56M High: $223.56M avg. 42.39% |
FAQ
What is Leap Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.49% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -39.45M, average is -62.13M and high is -21.67M.
What is Leap Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 750.45% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $34.48M, average is $34.48M and high is $34.48M.
What is Leap Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 25.00% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.93, average is -$1.55 and high is $-1.06.
What is the best performing analyst?
In the last twelve months analysts have been covering Leap Therapeutics stock. The most successful analyst is Swayampakula Ramakanth.